Virginie Verkarre

6PUBLICATIONS
74CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 04, 2025
Heart allograft rejection: molecular diagnosis using intra-graft targeted gene expression profiling.

Alessia Giarraputo, Guillaume Coutance, Jignesh K Patel

|Jun 19, 2023
Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma.

Guillaume Davidson, Alexandra Helleux, Yann A Vano

|Jan 25, 2023
A novel VCP::TFE3 gene fusion resulting from t(X;9)(p11.23;p13.3) chromosome translocation in TFE3 rearranged renal cancer cell carcinoma.

Marie Auvray Kuentz, Hélène Blons, Anne Paule Gimenez-Roqueplo

|Nov 14, 2022
An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas.

Xiaofan Lu, Yann Vano, Alexandra Helleux

|Sep 06, 2022
Plasma CD27, a Surrogate of the Intratumoral CD27-CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma.

Nadine Benhamouda, Ikuan Sam, Nicolas Epaillard

|Sep 17, 2021
Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1.

Aurélien Morini, Tom Drossart, Marc-Olivier Timsit

Pageof 1

Frequent Collaborators

3 joint publications

Stéphane Oudard

3 joint publications

Yann Vano

2 joint publications

Xiaoping Su

2 joint publications

Mostefa Bennamoun